FDA NDC Directory · JSON-LD · Markdown
NDC 50268-875 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | AvPAK |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA212277 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | VENLAFAXINE HYDROCHLORIDE (150 mg/1) |
| Marketing started | 20250225 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).